Delivery Order SPE2DB22D1106-SPE2DB25FEQU9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a ceiling value of $9,670.51. This is a firm fixed price delivery order with an ultimate completion date of October 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $8.55K to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,670.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed by the prime contractor's Corporate Office, located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $18,566.92 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the company's...
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $16,588.64 to AmerisourceBergen Drug Corp for supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used in melanoma and other oncological treatments, reflecting the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQU9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $19.3K to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by June 23, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical supply vehicle valued through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's DLA contracts support Defense Health Agency operations and other federal healthcare customers with specialty pharmaceuticals across multiple therapeutic domains. Mekinist is a targeted cancer therapy used in melanoma and other oncology treatments, reflecting the specialized medical products the contractor supplies to support military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 5/30/25 |